Form 4: Myomo Inc. Executive Harry Kovelman Reports Stock Disposal for Tax Obligations

Harry Kovelman, Chief Medical Officer of Myomo, Inc., disposed of 147 shares of common stock on March 5, 2024, to cover income tax obligations arising from the vesting of restricted stock units.

Summary

• On March 5, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., disposed of 147 shares of common stock.
• The transaction was executed to cover income tax obligations related to the vesting of restricted stock units on March 2, 2024.
• The sale price was $3.88 per share.
• Following the transaction, Kovelman directly owns 140,317 shares of Myomo, Inc.
• The transaction was completed under a pre-existing arrangement made in November 2020.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a routine stock disposal for tax purposes, which was pre-planned. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's stock.

Key Dates